The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Open accessAbstract
The c-kit proto-oncogene encodes a receptor tyrosine kinase. Binding of c-kit ligand, stem cell factor (SCF) to c-kit receptor (c-kitR) is known to activate c-kitR tyrosine kinase, thereby leading to autophosphorylation of c-kitR on tyrosine and to association of c-kitR with substrates such as phosphatidylinositol 3-kinase (PI3K). In a human mast cell leukemia cell line HMC-1, c-kitR was found to be constitutively phosphorylated on tyrosine, activated, and associated with PI3K without the addition of SCF. The expression of SCF mRNA transcript in HMC-1 cells was not detectable by means of PCR after reverse transcription (RT-PCR) analysis, suggesting that the constitutive activation of c-kitR was ligand independent. Sequencing of whole coding region of c-kit cDNA revealed that c-kit genes of HMC-1 cells were composed of a normal, wild-type allele and a mutant allele with two point mutations resulting in intracellular amino acid substitutions of Gly-560 for Val and Val-816 for Asp. Amino acid sequences in the regions of the two mutations are completely conserved in all of mouse, rat, and human c-kit. In order to determine the causal role of these mutations in the constitutive activation, murine c-kit mutants encoding Gly-559 and/or Val-814, corresponding to human Gly-560 and/or Val-816, were constructed by site-directed mutagenesis and expressed in a human embryonic kidney cell line, 293T cells. In the transfected cells, both c-kitR (Gly-559, Val-814) and c-kitR (Val-814) were abundantly phosphorylated on tyrosine and activated in immune complex kinase reaction in the absence of SCF, whereas tyrosine phosphorylation and activation of c-kitR (Gly-559) or wild-type c-kitR was modest or little, respectively. These results suggest that conversion of Asp-816 to Val in human c-kitR may be an activating mutation and responsible for the constitutive activation of c-kitR in HMC-1 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene
Geissler, E. N., Ryan, M. A., & Housman, D. E. (1988) · Cell · doi:10.1016/0092-8674(88)90020-7 · Cited by 1,287
Cited by
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Metcalfe, D. D. (2008) · Blood · doi:10.1182/blood-2007-11-078097 · Cited by 536
Zhang, L. Y., Smith, M. L., Schultheis, B., Fitzgibbon, J., Lister, T. A., Melo, J. V., Cross, N. C. P., & Cavenagh, J. D. (2006) · Leukemia Research · doi:10.1016/j.leukres.2005.08.015 · Cited by 129
Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Pardanani, A. (2023) · American Journal of Hematology · doi:10.1002/ajh.26962 · Cited by 132
Mast cell activation syndromes: definition and classification
Valent, P. (2013) · Allergy · doi:10.1111/all.12126 · Cited by 120
Piao, X., & Bernstein, A. (1996) · Blood · doi:10.1182/blood.v87.8.3117.bloodjournal8783117 · Cited by 112
Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders
Schwartz, L. B. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00020-0 · Cited by 110
A germline mutation in KIT in familial diffuse cutaneous mastocytosis
Tang, X., Boxer, M., Drummond, A., Ogston, P., Hodgins, M., & Burden, A. D. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.015156 · Cited by 81
Midostaurin: a magic bullet that blocks mast cell expansion and activation
Valent, P., Akin, C., Hartmann, K., George, T. I., Sotlar, K., Peter, B., Gleixner, K. V., Blatt, K., Sperr, W. R., Manley, P. W., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx290 · Cited by 79
Mast-cell responses in the development of asthma
Bingham, C. O., & Austen, K. F. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90056-3 · Cited by 80
Gülen, T., Hägglund, H., Dahlén, B., & Nilsson, G. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12410 · Cited by 75
Mast cell activation syndromes: Collegium Internationale Allergologicum update 2022
Valent, P., Hartmann, K., Bonadonna, P., Niedoszytko, M., Triggiani, M., Arock, M., & Brockow, K. (2022) · International Archives of Allergy and Immunology · doi:10.1159/000524532 · Cited by 55
Kosmider, O., Denis, N., Lacout, C., Vainchenker, W., Dubreuil, P., & Moreau-Gachelin, F. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.11.009 · Cited by 49
Hauswirth, A. W., Escribano, L., Prados, A., Nuñez, R., Mirkina, I., Kneidinger, M., Florian, S., Sonneck, K., Vales, A., Schernthaner, G.-H., et al. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100404 · Cited by 48
Pak and Rac GTPases promote oncogenic KIT–induced neoplasms
Martin, H., Mali, R. S., Ma, P., Chatterjee, A., Ramdas, B., Sims, E., Munugalavadla, V., Ghosh, J., Mattingly, R. R., Visconte, V., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67509 · Cited by 45
Human mast cells produce and differentially express both soluble and membrane‐bound stem cell factor
Welker, Grabbe, Gibbs, Zuberbier, & Henz (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00519.x · Cited by 41
Anti-IL-5 and hypereosinophilic syndromes
SUTTON, S., ASSAAD, A., & ROTHENBERG, M. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.02.006 · Cited by 40
Mast cell activation disease and the modern epidemic of chronic inflammatory disease
Afrin, L. B. (2016) · Translational Research · doi:10.1016/j.trsl.2016.01.003 · Cited by 39
Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management
Pardanani, A. (2011) · American Journal of Hematology · doi:10.1002/ajh.21982 · Cited by 26
Serotonin and its 5-HT1 receptor in human mastocytosis
Ritter, M., El-Nour, H., Hedblad, M.-A., Butterfield, J. H., Beck, O., Stephanson, N., Holst, M., Giscombe, R., Azmitia, E. C., & Nordlind, K. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.651222 · Cited by 17
Self-citation
Metadata
- Authors
- Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J. H., Ashman, L. K., & Kanayama, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-10-01
- Volume
- 92
- Issue
- 4
- Pages
- 1736-1744
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2165720262
- Cited by
- 816
- References
- 1
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.